Cargando…

Clinical Aspects of Melatonin Intervention in Alzheimer’s Disease Progression

Melatonin secretion decreases in Alzheimer´s disease (AD) and this decrease has been postulated as responsible for the circadian disorganization, decrease in sleep efficiency and impaired cognitive function seen in those patients. Half of severely ill AD patients develop chronobiological day-night r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardinali, Daniel P, Furio, Analía M, Brusco, Luis I
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001215/ https://www.ncbi.nlm.nih.gov/pubmed/21358972 http://dx.doi.org/10.2174/157015910792246209

Ejemplares similares

Melatonin Therapy in Patients with Alzheimer’s Disease
por: Cardinali, Daniel P., et al.
Publicado: (2014)

Melatonin: Clinical Perspectives in Neurodegeneration
por: Cardinali, Daniel P.
Publicado: (2019)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

Melatonin in Alzheimer's disease and other neurodegenerative disorders
por: Srinivasan, V, et al.
Publicado: (2006)

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
por: Pérez-Lloret, Santiago, et al.
Publicado: (2021)

An Exploratory Study of Sleep-Wake Differences of Autonomic Activity in Patients with Mild Cognitive Impairment: The Role of Melatonin as a Modulating Factor
por: Abulafia, Carolina, et al.
Publicado: (2023)

Melatonin in Alzheimer’s Disease
por: Lin, Li, et al.
Publicado: (2013)

An Assessment of Melatonin’s Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn
por: Cardinali, Daniel P.
Publicado: (2019)

Possible Application of Melatonin in Long COVID
por: Cardinali, Daniel P., et al.
Publicado: (2022)

Melatonin as a Chronobiotic/Cytoprotective Agent in REM Sleep Behavior Disorder
por: Cardinali, Daniel P., et al.
Publicado: (2023)

Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
por: Shukla, Mayuri, et al.
Publicado: (2017)

Melatonin in Mitochondrial Dysfunction and Related Disorders
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2011)

Autism Spectrum Disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin
por: Brown, Gregory M., et al.
Publicado: (2021)

Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease
por: Roy, Jaydeep, et al.
Publicado: (2021)

Clinical Aspects of Foot Health in Individuals with Alzheimer’s Disease
por: López-López, Daniel, et al.
Publicado: (2018)

Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
por: Cardinali, Daniel P., et al.
Publicado: (2020)

Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
por: Cardinali, Daniel P, et al.
Publicado: (2022)

Falls Risk, Circadian Rhythms and Melatonin: Current Perspectives
por: Goswami, Nandu, et al.
Publicado: (2020)

Melatonin, immune function and aging
por: Srinivasan, V, et al.
Publicado: (2005)

Melatonin as an Add-On Treatment of COVID-19 Infection: Current Status
por: Brown, Gregory M., et al.
Publicado: (2021)

Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
por: He, Hongwen, et al.
Publicado: (2010)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
por: Pachón-Angona, Irene, et al.
Publicado: (2019)

Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline
por: Nous, Amber, et al.
Publicado: (2021)

Melatonin levels in the Alzheimer’s disease continuum: a systematic review
por: Nous, Amber, et al.
Publicado: (2021)

Effects of melatonin on cardiovascular diseases: progress in the past year
por: Sun, Hang, et al.
Publicado: (2016)

Measurement of melatonin in body fluids: Standards, protocols and procedures
por: de Almeida, Eduardo Alves, et al.
Publicado: (2010)

Transcriptomics in Alzheimer’s Disease: Aspects and Challenges
por: Bagyinszky, Eva, et al.
Publicado: (2020)

Functional aspects of meningeal lymphatics in aging and Alzheimer’s disease
por: Da Mesquita, Sandro, et al.
Publicado: (2018)

Metabolome in progression to Alzheimer's disease
por: Orešič, M, et al.
Publicado: (2011)

Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
por: Zare, Hadis, et al.
Publicado: (2019)

Melatonin Mediated Regulation of Drought Stress: Physiological and Molecular Aspects
por: Sharma, Anket, et al.
Publicado: (2019)

Developmental and Early Life Origins of Hypertension: Preventive Aspects of Melatonin
por: Tain, You-Lin, et al.
Publicado: (2022)

Cadmium-Induced Disruption in 24-h Expression of Clock and Redox Enzyme Genes in Rat Medial Basal Hypothalamus: Prevention by Melatonin
por: Jiménez-Ortega, Vanesa, et al.
Publicado: (2011)

Melatonin and Abeta, Macular Degeneration and Alzheimers Disease: Same Disease, Different Outcomes?
por: Vladan, Bajic, et al.
Publicado: (2012)

Melatonin Ameliorates the Progression of Alzheimer's Disease by Inducing TFEB Nuclear Translocation, Promoting Mitophagy, and Regulating NLRP3 Inflammasome Activity
por: Fan, Li, et al.
Publicado: (2022)

The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease
por: Shen, Shengnan, et al.
Publicado: (2022)

Alzheimer’s Disease: Epidemiology and Clinical Progression
por: Tahami Monfared, Amir Abbas, et al.
Publicado: (2022)

Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects
por: Lee, Hee Jae, et al.
Publicado: (2018)

Melatonin May Curtail the Metabolic Syndrome: Studies on Initial and Fully Established Fructose-Induced Metabolic Syndrome in Rats
por: Cardinali, Daniel P., et al.
Publicado: (2013)

Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration
por: Cardinali, Daniel P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_roeu3alf1n3tq5isbp4f9qa8ml